JS
Highly rated in
10
conditions
Highly rated in
10
conditions
Check Dr. Jeremy M. Shefner's experience treating your condition:
About Dr. Jeremy M. Shefner

Jeremy Shefner is a Neurologist in Phoenix, Arizona. Shefner has been practicing medicine for over 39 years and is highly rated in 10 conditions, according to our data. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Parkinson's Disease, and Dementia. He is licensed to treat patients in Arizona and New York. Shefner is currently accepting new patients.

His clinical research consists of co-authoring 110 peer reviewed articles and participating in 11 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Jeremy M. Shefner it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Jeremy M. Shefner accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Bright Health
  •  Medica
  •  Cigna

Call to see if your plan is accepted.
Locations
240 W Thomas Rd, #400, Phoenix, AZ 85013
Background & Education
Graduate Institution
Northwestern University Feinberg Medical School, 1983
Specialties
Neurology
Licenses
Psychiatry & Neurology in NY
Hospital Affiliations
St Josephs Hospital And Medical Center
Yavapai Regional Medical Center - West
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


11 Clinical Trials

Home-based Remote Digital Monitoring to Assess ALS Progression (Track ALS)
A Phase 2 Randomized, Placebo Controlled Trial of Tocilizumab in ALS Subjects
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance
ALS Testing Through Home-based Outcome Measures (ALS AT HOME)
Open Label, Off Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Ciprofloxacin/Celecoxib Combination in Patients With ALS
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
The Experimental Treatment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in Amyotrophic Lateral Sclerosis (ALS)
Electrical Impedance Myography as an Outcome Measure in ALS Clinical Trials
View 10 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors